| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-16 | Borthwick Kathleen | officer | Award | 15,610 | $7.64 | $119K |
| 2026-03-16 | Chou William | director, officer | Award | 58,000 | $7.64 | $443K |
| 2026-01-08 | Chou William | director, officer | Option exercise | 10,000 | — | — |
| 2026-01-08 | Borthwick Kathleen | officer | Option exercise | 5,000 | — | — |
| 2026-01-08 | Chou William | director, officer | Sale | 4,076 | $18.44 | $75K |
| 2026-01-08 | Borthwick Kathleen | officer | Sale | 2,062 | $18.44 | $38K |
| 2025-09-15 | Lynx1 Capital Management LP | 10%+ owner | Buy | 11,900 | $6.99 | $83K |
| 2025-09-12 | Lynx1 Capital Management LP | 10%+ owner | Buy | 19,783 | $6.99 | $138K |
| 2025-09-11 | Lynx1 Capital Management LP | 10%+ owner | Buy | 325 | $6.96 | $2K |
| Filed | Form | Filer | Stake | Shares | |
|---|---|---|---|---|---|
| 2026-07-02 | SCHEDULE 13D | Lynx1 Capital Management LP | 21.00% | 673,759 | view → |
| 2026-06-25 | SCHEDULE 13G | Baselake Partners, LP | — | — | view → |
| 2025-07-21 | SCHEDULE | ORBIMED ADVISORS LLC | 7.82% | 243,878 | view → |
| 2024-04-12 | SC | ORBIMED ADVISORS LLC | — | — | view → |
| Filed | Form | Issuer | Stake | Shares | |
|---|---|---|---|---|---|
| 2026-01-27 | SCHEDULE | Mirum Pharmaceuticals, Inc. MIRM | 6.80% | 4,108,404 | view → |
| 2023-09-05 | SC | Mirum Pharmaceuticals, Inc. MIRM | — | — | view → |
| 2022-09-26 | SC | Phathom Pharmaceuticals, Inc. PHAT | — | — | view → |
| 2020-12-18 | SC | Mirum Pharmaceuticals, Inc. MIRM | — | — | view → |
| 2020-04-29 | SC | Mirum Pharmaceuticals, Inc. MIRM | — | — | view → |
Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.
See pricing →